According to the Zhitong Finance App, Deqi Pharmaceutical-B (06996) announced that on July 16, 2026, it would spend approximately HK$1.039 million to repurchase 224,500 shares.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.